GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

The partnership between the pharmaceutical giant and the university aims to create a vaccine or vaccines which target cells ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

A new cancer vaccine that ‘stops disease before you get it’ is being created by pharmaceutical giant GSK and the University ...

Alphabet also remains a popular pick among hedge fund managers. According to Insider Monkey data, 202 hedge fund investors ...